Asia Pacific Cancer Biomarkers Market Size, Share & Industry Trends Analysis Report By Profiling Technologies, By Application, By Type, By Cancer Type, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Cancer Biomarkers Market would witness Market growth of 17.8% CAGR during the forecast period (2022-2028).

The utilization of RNA, DNA, microRNAs, and proteins in cancer detection involves molecular changes. To lessen the physical and emotional impact of cancer on patients and their families, governments in various nations are focused on investing in cancer prevention and early intervention. Additionally, governmental healthcare departments are actively involved in cancer research and therapy development. The rising incidence of cancer is predicted to spur innovation and advancement in the field of biomarker-based cancer diagnostics.

Due to an increase in the occurrence of different types of cancer such as prostate, breast, and lung cancer, the worldwide cancer biomarkers Market is predicted to develop significantly over the forecast period. Additionally, the rising importance of biological and targeted medicinal therapies, technical improvements, and the precision and reliability of cancer biomarkers all contribute to the Market 's growth. Additionally, increased government and public-private sector investments in cancer diagnostics R&D have a favorable impact on the industry. The cancer biomarkers Market is expected to benefit from advances in cancer research and a substantial unfulfilled need for cancer diagnostics.

The Asia Pacific witnessed increased usage of biomarker-based tests for cancer detection and the deployment of technologically sophisticated instruments by laboratories in the area. Additionally, increased funding and investments from public and private organizations in biomarker research and development, as well as the use of biomarkers in patient stratification and the medication development process, are expected to propel the Market in the area forward.

One of the top causes of death in Asian countries is cancer. In addition, the National Cancer Centre reported that three forms of blood malignancies (multiple lymphoma, malignant myeloma, and leukemia) accounted for some share of all cancers in Japan. After the United States and China, India has the world's third-highest number of blood cancer sufferers. The cancer rate has risen dramatically in recent decades and is anticipated to continue to rise substantially during the prediction period. Other important Market drivers include a more efficient drug delivery mechanism, non-invasive technologies, and higher survival rates. On the other side, the Market is hampered by the significant cost of diagnosis & products, reimbursement concerns, and the necessity for quick processing.

The China Market dominated the Asia Pacific Cancer Biomarkers Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $2,797 million by 2028. The Japan Market is experiencing a CAGR of 17.1% during (2022 - 2028). Additionally, The India Market would exhibit CAGR of 18.6% during (2022 - 2028).

Based on Profiling Technologies, the Market is segmented into Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, and Cytogenetics. Based on Application, the Market is segmented into Diagnostics, Research & Development, Prognostics, Risk Assessment, and Others. Based on Type, the Market is segmented into Protein, Genetic, and Others. Based on Cancer Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Thyroid Cancer, Melanoma & Leukemia, Kidney & Bladder Cancer, Non-Hodgkin's Lymphoma, Prostate Cancer, and Others. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Cancer Biomarkers Market is Projected to reach USD 34.3 Billion by 2028, at a CAGR of 16.8%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Agilent Technologies, Inc., and Merck & Co., Inc.

Scope of the Study

Market Segments Covered in the Report:

By Profiling Technologies

• Omics Technologies
• Imaging Technologies
• Immunoassay
• Bioinformatics
• Cytogenetics

By Application

• Diagnostics
• Research & Development
• Prognostics
• Risk Assessment
• Others

By Type

• Protein
• Genetic
• Others

By Cancer Type

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Thyroid Cancer
• Melanoma & Leukemia
• Kidney & Bladder Cancer
• Non-Hodgkin's Lymphoma
• Prostate Cancer
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• BioMérieux S.A.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Agilent Technologies, Inc.
• Merck & Co., Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cancer Biomarkers Market, by Profiling Technologies
1.4.2 Asia Pacific Cancer Biomarkers Market, by Application
1.4.3 Asia Pacific Cancer Biomarkers Market, by Type
1.4.4 Asia Pacific Cancer Biomarkers Market, by Cancer Type
1.4.5 Asia Pacific Cancer Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Cancer Biomarkers Market

Chapter 4. Asia Pacific Cancer Biomarkers Market by Profiling Technologies
4.1 Asia Pacific Omics Technologies Market by Country
4.2 Asia Pacific Imaging Technologies Market by Country
4.3 Asia Pacific Immunoassay Market by Country
4.4 Asia Pacific Bioinformatics Market by Country
4.5 Asia Pacific Cytogenetics Market by Country

Chapter 5. Asia Pacific Cancer Biomarkers Market by Application
5.1 Asia Pacific Diagnostics Market by Country
5.2 Asia Pacific Research & Development Market by Country
5.3 Asia Pacific Prognostics Market by Country
5.4 Asia Pacific Risk Assessment Market by Country
5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Cancer Biomarkers Market by Type
6.1 Asia Pacific Protein Market by Country
6.2 Asia Pacific Genetic Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Cancer Biomarkers Market by Cancer Type
7.1 Asia Pacific Breast Cancer Market by Country
7.2 Asia Pacific Lung Cancer Market by Country
7.3 Asia Pacific Colorectal Cancer Market by Country
7.4 Asia Pacific Thyroid Cancer Market by Country
7.5 Asia Pacific Melanoma & Leukemia Market by Country
7.6 Asia Pacific Kidney & Bladder Cancer Market by Country
7.7 Asia Pacific Non-Hodgkin's Lymphoma Market by Country
7.8 Asia Pacific Prostate Cancer Market by Country
7.9 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Cancer Biomarkers Market by Country
8.1 China Cancer Biomarkers Market
8.1.1 China Cancer Biomarkers Market by Profiling Technologies
8.1.2 China Cancer Biomarkers Market by Application
8.1.3 China Cancer Biomarkers Market by Type
8.1.4 China Cancer Biomarkers Market by Cancer Type
8.2 Japan Cancer Biomarkers Market
8.2.1 Japan Cancer Biomarkers Market by Profiling Technologies
8.2.2 Japan Cancer Biomarkers Market by Application
8.2.3 Japan Cancer Biomarkers Market by Type
8.2.4 Japan Cancer Biomarkers Market by Cancer Type
8.3 India Cancer Biomarkers Market
8.3.1 India Cancer Biomarkers Market by Profiling Technologies
8.3.2 India Cancer Biomarkers Market by Application
8.3.3 India Cancer Biomarkers Market by Type
8.3.4 India Cancer Biomarkers Market by Cancer Type
8.4 South Korea Cancer Biomarkers Market
8.4.1 South Korea Cancer Biomarkers Market by Profiling Technologies
8.4.2 South Korea Cancer Biomarkers Market by Application
8.4.3 South Korea Cancer Biomarkers Market by Type
8.4.4 South Korea Cancer Biomarkers Market by Cancer Type
8.5 Singapore Cancer Biomarkers Market
8.5.1 Singapore Cancer Biomarkers Market by Profiling Technologies
8.5.2 Singapore Cancer Biomarkers Market by Application
8.5.3 Singapore Cancer Biomarkers Market by Type
8.5.4 Singapore Cancer Biomarkers Market by Cancer Type
8.6 Malaysia Cancer Biomarkers Market
8.6.1 Malaysia Cancer Biomarkers Market by Profiling Technologies
8.6.2 Malaysia Cancer Biomarkers Market by Application
8.6.3 Malaysia Cancer Biomarkers Market by Type
8.6.4 Malaysia Cancer Biomarkers Market by Cancer Type
8.7 Rest of Asia Pacific Cancer Biomarkers Market
8.7.1 Rest of Asia Pacific Cancer Biomarkers Market by Profiling Technologies
8.7.2 Rest of Asia Pacific Cancer Biomarkers Market by Application
8.7.3 Rest of Asia Pacific Cancer Biomarkers Market by Type
8.7.4 Rest of Asia Pacific Cancer Biomarkers Market by Cancer Type

Chapter 9. Company Profiles
9.1 BioMérieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Qiagen N.V.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Product Launches and Product Expansions:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Merck & Co., Inc. (Merck Millipore)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses

TABLE 1 Asia Pacific Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Omics Technologies Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Omics Technologies Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Imaging Technologies Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Imaging Technologies Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Bioinformatics Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Bioinformatics Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Cytogenetics Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Cytogenetics Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Research & Development Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Research & Development Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Prognostics Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Prognostics Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Risk Assessment Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Risk Assessment Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Protein Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Protein Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Genetic Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Genetic Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Colorectal Cancer Market by Country, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Colorectal Cancer Market by Country, 2022 - 2028, USD Million
TABLE 43 Asia Pacific Thyroid Cancer Market by Country, 2018 - 2021, USD Million
TABLE 44 Asia Pacific Thyroid Cancer Market by Country, 2022 - 2028, USD Million
TABLE 45 Asia Pacific Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 46 Asia Pacific Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 47 Asia Pacific Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 48 Asia Pacific Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 49 Asia Pacific Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 50 Asia Pacific Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 51 Asia Pacific Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 52 Asia Pacific Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 53 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 54 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 55 Asia Pacific Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 56 Asia Pacific Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 57 China Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 58 China Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 59 China Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 60 China Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 61 China Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 62 China Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 63 China Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 64 China Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 65 China Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 66 China Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 67 Japan Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 68 Japan Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 69 Japan Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 70 Japan Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 71 Japan Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 72 Japan Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 73 Japan Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 74 Japan Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 75 Japan Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 76 Japan Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 77 India Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 78 India Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 79 India Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 80 India Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 81 India Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 82 India Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 83 India Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 84 India Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 85 India Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 86 India Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 87 South Korea Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 88 South Korea Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 89 South Korea Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 90 South Korea Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 91 South Korea Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 92 South Korea Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 93 South Korea Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 94 South Korea Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 95 South Korea Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 96 South Korea Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 97 Singapore Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 98 Singapore Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 99 Singapore Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 100 Singapore Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 101 Singapore Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 102 Singapore Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 103 Singapore Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 104 Singapore Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 105 Singapore Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 106 Singapore Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 107 Malaysia Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 108 Malaysia Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 109 Malaysia Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 110 Malaysia Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 111 Malaysia Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 112 Malaysia Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 113 Malaysia Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 114 Malaysia Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 115 Malaysia Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 116 Malaysia Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 117 Rest of Asia Pacific Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 118 Rest of Asia Pacific Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 119 Rest of Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 120 Rest of Asia Pacific Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 121 Rest of Asia Pacific Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 122 Rest of Asia Pacific Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 123 Rest of Asia Pacific Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 124 Rest of Asia Pacific Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 125 Rest of Asia Pacific Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 126 Rest of Asia Pacific Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 127 Key information – BioMérieux S.A.
TABLE 128 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 129 Key information – Becton, Dickinson and Company
TABLE 130 Key Information – Abbott Laboratories
TABLE 131 Key Information – Thermo Fisher Scientific, Inc.
TABLE 132 key information – Illumina, Inc.
TABLE 133 Key Information – Bio-Rad Laboratories, Inc.
TABLE 134 Key Information – Qiagen N.V.
TABLE 135 key Information – Agilent Technologies, Inc.
TABLE 136 KEY INFORMATION - MERCK & CO., INC.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 3 Swot analysis: thermo fisher scientific, inc.